Topoisomerase IIα Expression in Breast Cancer: Correlation with Outcome Variables
- 1 May 2000
- journal article
- Published by Elsevier in Laboratory Investigation
- Vol. 13 (5) , 542-547
- https://doi.org/10.1038/modpathol.3880094
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Predictive value of topoisomerase IIα and other prognostic factors for epirubicin chemotherapy in advanced breast cancerBritish Journal of Cancer, 1998
- Differential expression of the topoisomerase IIα and β genes in human breast cancersBritish Journal of Cancer, 1996
- Relationship between expression of topoisomerase II isoforms and intrinsic sensitivity to topoisomerase II inhibitors in breast cancer cell linesBritish Journal of Cancer, 1995
- DNA transport by a type II DNA topoisomerase: Evidence in favor of a two-gate mechanismCell, 1994
- Cellular Determinants of Sensitivity and Resistance to DNA Topoisomerase InhibitorsCancer Investigation, 1994
- p53-dependent apoptosis modulates the cytotoxicity of anticancer agentsCell, 1993
- Human cells express two differentially spliced forms of topoisomerase IIβ mRNANucleic Acids Research, 1993
- Characterization and immunological identification of cDNA clones encoding two human DNA topoisomerase II isozymes.Proceedings of the National Academy of Sciences, 1989
- DNA TOPOISOMERASE POISONS AS ANTITUMOR DRUGSAnnual Review of Biochemistry, 1989
- Biochemical basis for the interactions of type I and type II topoisomerases with DNAPharmacology & Therapeutics, 1989